Alyeska Investment Group, L.P. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | Alyeska Investment Group, L.P. | 6,707,497 5.760% | 1,725,824 (+34.64%) | Filing |
| 2024-11-14 4:38 pm Sale | 2024-09-30 | 13G | Applied Therapeutics, Inc. APLT | Alyeska Investment Group, L.P. | 4,981,673 4.200% | -2,733,524 (-35.43%) | Filing |
| 2024-02-14 1:50 pm Purchase | 2023-12-31 | 13G | Applied Therapeutics, Inc. APLT | Alyeska Investment Group, L.P. | 7,715,197 9.990% | 2,910,197 (+60.57%) | Filing |
| 2023-02-14 2:04 pm Purchase | 2022-12-31 | 13G | Applied Therapeutics, Inc. APLT | Alyeska Investment Group, L.P. | 4,805,000 9.990% | 4,805,000 (New Position) | Filing |